Cypress Capital Management (Delaware)’s Thermo Fisher Scientific TMO Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,455	Closed	-$2.26M	–	156
2022 Q3	$2.26M	Buy	4,455 +1,225	+38%	+$686K	0.42%	59
2022 Q2	$1.75M	Hold	3,230	–	–	0.26%	73
2022 Q1	$1.91M	Hold	3,230	–	–	0.24%	80
2021 Q4	$2.15M	Buy	3,230 +175	+6%	+$109K	0.24%	82
2021 Q3	$1.54M	Hold	3,055	–	–	0.2%	81
2021 Q2	$1.54M	Hold	3,055	–	–	0.2%	82
2021 Q1	$1.39M	Hold	3,055	–	–	0.19%	84
2020 Q4	$1.42M	Hold	3,055	–	–	0.19%	82
2020 Q3	$1.35M	Sell	3,055 -500	-14%	-$207K	0.21%	79
2020 Q2	$1.29M	Hold	3,555	–	–	0.21%	79
2020 Q1	$1.01M	Hold	3,555	–	–	0.2%	78
2019 Q4	$1.16M	Hold	3,555	–	–	0.18%	86
2019 Q3	$1.04M	Hold	3,555	–	–	0.17%	84
2019 Q2	$1.04M	Sell	3,555 -150	-4%	-$41.3K	0.18%	83
2019 Q1	$1.01M	Buy	3,705 +30	+0.8%	+$7.47K	0.19%	80
2018 Q4	$822K	Hold	3,675	–	–	0.17%	78
2018 Q3	$897K	Hold	3,675	–	–	0.16%	76
2018 Q2	$761K	Buy	+3,675	New	+$780K	0.14%	89
2018 Q1	–	Sell	-1,349	Closed	-$256K	–	147
2017 Q4	$256K	Sell	1,349 -1	-0.1%	-$192	0.05%	131
2017 Q3	$255K	Sell	1,350 -120	-8%	-$21.7K	0.05%	120
2017 Q2	$256K	Hold	1,470	–	–	0.06%	106
2017 Q1	$226K	Hold	1,470	–	–	0.06%	107
2016 Q4	$207K	Buy	+1,470	New	+$217K	0.05%	105

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cypress Capital Management (Delaware)'s TMO Position: Q4 2022 in Review

Cypress Capital Management (Delaware) sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 4,455 shares — an estimated $2.26M sold.

Cypress Capital Management (Delaware) first reported a position in TMO in Q4 2016 and held it in 23 quarters. The position peaked at $2.26M in Q3 2022. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

Cypress Capital Management (Delaware) reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
Cypress Capital Management (Delaware) sold 4,455 Thermo Fisher Scientific shares in Q4 2022, an estimated $2.26M.
Cypress Capital Management (Delaware) first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 23 quarters.
Cypress Capital Management (Delaware)'s Thermo Fisher Scientific position peaked at $2.26M in Q3 2022.
2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2022.